Status:

COMPLETED

Navio With Total Knee Arthroplasty

Lead Sponsor:

Smith & Nephew, Inc.

Conditions:

Total Knee Arthroplasty

Arthroplasty of Knee

Eligibility:

All Genders

Up to 80 years

Brief Summary

The purpose of this study is to demonstrate superior accuracy with the Navio ™ Robotic-assisted Surgical System in achieving desired post-operative mechanical alignment, compared to TKA procedures usi...

Detailed Description

Total Knee Arthroplasty (TKA) has become an effective and reliable treatment for arthritis of the knee (1). TKA is associated with low morbidity and mortality, and its effectiveness in reducing joint ...

Eligibility Criteria

Inclusion

  • Subject requires primary total knee arthroplasty with the Journey II BCS or Cruciate-Retraining (CR) Systems due to degenerative joint disease (primary diagnosis of osteoarthritis, post-traumatic arthritis, avascular necrosis, rheumatoid arthritis.
  • Subject was considered skeletally mature at the time of cone implantation (at least 18 years or older.)
  • Subject agrees to consent to and to follow the study visit schedule (as defined in the study protocol and informed consent form) by signing the IRB/EC approved informed consent form.
  • Subject plans to be available through two (2) years postoperative follow-up.

Exclusion

  • Subject has BMI ≥ 40.
  • Subject has condition(s) that may interfere with the TKA survival or outcome (i.e., Paget's or Charcot's disease, vascular insufficiency, muscular atrophy, uncontrolled diabetes, moderate to severe renal insufficiency or neuromuscular disease, or an active, local infection).
  • Subject is deemed by investigator to require a constrained or deep dish tibial insert.
  • Subject has inadequate bone stock to support the device (severe osteopenia, history of severe osteoporosis or severe osteopenia).
  • Subject has mental or neurologic condition(s) that may pre-empt the ability or willingness to restrict activities.
  • Subject is 80 years of age or older.
  • Subject is a prisoner or impending incarceration.

Key Trial Info

Start Date :

November 13 2017

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

May 27 2021

Estimated Enrollment :

122 Patients enrolled

Trial Details

Trial ID

NCT03317834

Start Date

November 13 2017

End Date

May 27 2021

Last Update

October 8 2024

Active Locations (6)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 2 (6 locations)

1

Hedley Orthopedics

Phoenix, Arizona, United States, 85016

2

Orthopaedic Associates of Central Arizona

Scottsdale, Arizona, United States, 86305

3

San Diego Orthopaedic

San Diego, California, United States, 92103

4

Bronson Health

Kalamazoo, Michigan, United States, 49006